Cargando…
SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in...
Autores principales: | Selkirk, Ewan, Patel, Rahima, Hoyle, Anna, Lie-a-Ling, Michael, Smith, Duncan, Swift, Joe, Lacaud, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663857/ https://www.ncbi.nlm.nih.gov/pubmed/36387443 http://dx.doi.org/10.1016/j.heliyon.2022.e11362 |
Ejemplares similares
-
SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination
por: Lv, Tingting, et al.
Publicado: (2022) -
RUNX1 Dosage in Development and Cancer
por: Lie-a-ling, Michael, et al.
Publicado: (2020) -
SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers
por: Matsuura, Shun, et al.
Publicado: (2013) -
Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium
por: Lie-A-Ling, Michael, et al.
Publicado: (2018) -
Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
por: Fei, Xiaobin, et al.
Publicado: (2022)